Ayurveda is an ancient eastern medical practice that’s been around over 5 thousand years. And while CBD isn’t anything new, modern medicine has only recently began conducting research.
The CBD sports nutrition sector had its game significantly boosted in 2018 when the World Anti-Doping Agency (WADA) removed the hemp-derived cannabinoid from its list of banned performance-enhancing substances – the market duly took off.
The COVID-19 pandemic and ongoing legal quagmire surrounding CBD supplements and foods in the US have knocked what was a booming category – along with scarce science and raw material pricing and QC concerns – but the sector is looking to economic and...
Royal DSM has entered into a broad commercial partnership with Colorado-based cannabinoid company Mile High Labs (MHL) for next generation science-backed cannabinoid solutions.
Despite a pessimistic outlook for the state of the CBD market, the CEO of a leading brand said there’s plenty of opportunity for companies committed to doing things the right way.
With US retail sales of cannabidiol-infused foods, beverages and supplements declining sharply in the past year and some early-adopters souring on the ingredient after experiencing lackluster ‘results,’ some players in the space are discontinuing their...
Contract research organization KGK Science Inc. will be acquired by Canadian investment issuer Myconic Capital Corp., it was announced yesterday. The deal is valued at as much as $16.5 million.
A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.
A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.
CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.
Consumer demand for CBD products has soared during lockdown, according to the Association for the Cannabinoid Industry (ACI), which estimates the sector will generate £690 million in annual sales this year, above a previous forecast of £526 million.
In a sign of further consolidation within the CBD/hemp products industry, THC Farmaceuticals Inc has announced it has acquired a contract manufacturer in Southern California.
Many of us know that valerian root, ashwagandha, chamomile and melatonin are helpful in delivering a good night’s rest. But how about CBN? Stuart Titus, PhD, CEO and president at Medical Marijuana, said that cannabinol hasn't really been available...
